Design, development, and evaluation of spray dried flurbiprofen loaded sustained release polymeric nanoparticles using QBD approach to manage inflammation
Drying Technology, 2023•Taylor & Francis
Spray-dried Flurbiprofen (FLB) loaded polymeric nanoformulation using Eudragit L 100 and
Ethylcellulose. They were optimized and evaluated. This study determined drug release (%)
and encapsulation efficiency (%) by developing a nanoparticulate system using the design
of experiment (DoE) approach. FLB is slightly soluble in water; it dissolves slowly and has a
low oral bioavailability. FLB-loaded polymeric nanoparticles were produced by solvent
evaporation and Spray drying technology. In this research, nanoparticle formulation was …
Ethylcellulose. They were optimized and evaluated. This study determined drug release (%)
and encapsulation efficiency (%) by developing a nanoparticulate system using the design
of experiment (DoE) approach. FLB is slightly soluble in water; it dissolves slowly and has a
low oral bioavailability. FLB-loaded polymeric nanoparticles were produced by solvent
evaporation and Spray drying technology. In this research, nanoparticle formulation was …
Abstract
Spray-dried Flurbiprofen (FLB) loaded polymeric nanoformulation using Eudragit L 100 and Ethylcellulose. They were optimized and evaluated. This study determined drug release (%) and encapsulation efficiency (%) by developing a nanoparticulate system using the design of experiment (DoE) approach. FLB is slightly soluble in water; it dissolves slowly and has a low oral bioavailability. FLB-loaded polymeric nanoparticles were produced by solvent evaporation and Spray drying technology. In this research, nanoparticle formulation was prepared by screening and optimization by approaching two different statistical methods (Plackett-Burman and Central composite Designs). The polymeric nanoparticles were evaluated for various characteristics, including drug release, percentage of encapsulation efficiency, X-ray diffraction (X-RD), surface morphology, and Fourier transform infrared (FTIR) spectroscopy. Based on the X-RD analysis, it was found that the drug was successfully incorporated into the polymeric nanoparticles. As a result of nanoparticles containing FLB, % Drug release values were found to be nearly 85-90% increased while % EE was observed in the range of 79-89%. An excellent sustained release, i.e., 14 h, is possible by combining Ethylcellulose (EC) and Eudragit L 100 (ED-100) polymers. The results are beneficial in identifying the ideal formulation parameters for effective encapsulation.
Abbreviations: FLB: Flurbiprofen; API: Active pharmaceutical ingredient; DR: Drug release; EE: Encapsulation efficiency; DoE: Design of experiment; X-RD: X-ray diffraction; FTIR: Fourier transform infrared spectroscopy.; PVA: Polyvinyl alcohol; EC: Ethylcellulose; EUGD: Eudragit L 100; NPs: Nanoparticles; PBD: Placket- Burman Design; CCD: Central Composite Design; CMV: Critical method variables; GIT: Gastrointestinal track; SLN: Solid lipid nanoparticles; NLC: Nanostructured lipid carriers; NSAID: Nonsteroidal anti-inflammatory drug; BCS: Biopharmaceutical classification system; PS: Particle size; PDI: Polydispersity Index; ZP: Zeta potential; FE-SEM: Field emission scanning electron microscopy; 2D: 2 Dimensional; 3D: 3 Dimensional
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果